Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Towards The Development of a Biologically Functional Tissue Engineered Vascular Graft

Ardila, Diana Catalina (2019) Towards The Development of a Biologically Functional Tissue Engineered Vascular Graft. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Download (3MB) | Preview


Coronary artery disease (CAD) is the leading cause of death worldwide [1], and it is predicted that 23 million deaths will be attributed to CAD by 2030. Treatment of CAD has required over 400,000 coronary artery bypass graft (CABG) surgeries every year [2], representing a cost to the country of nearly $439 billion in direct and indirect expenses annually [3]. As autologous veins are often unavailable for in CABG surgeries [4, 5], and commercially available synthetic grafts have shown limited efficacy when used in small diameter vessels [5-7], a readily available tissue engineered vascular graft (TEVG) for use in CABG surgeries would provide drastic improvements in patient care. Despite significant recent progress [7, 8], the development of a biologically functional TEVG that is biocompatible, biofunctional, and anti-thrombogenic has remained elusive [9, 10]. The primary goal of this dissertation is to fabricate a TEVG that supports and modulates the growth and collagen production of vascular smooth muscle cells (VSMCs) and promotes the formation of a functional endothelium. For this purpose, an initial assessment of biocompatibility was performed by culturing SMCs in gelatin/fibrinogen electrospun scaffolds, using exogenous TGFβ2 to modulate cell response. It was demonstrated that that TGFβ2 had a differential effect on cell proliferation, migration, and collagen deposition of SMCs growing in our biopolymer materials. In order to provide additional biofunctionality to the TEVG, a tubular scaffold able to release TGFβ2 was fabricated. The combination of gelatin and PCL at different ratios allowed elution tunability. The released TGFβ2 was bioactive and was able to modulate SMCs growth in vitro and in 3D culture. To evaluate anti-thrombogenicity and perform an additional assessment of biocompatibility, human derived endothelial cells (hCB-ECs) were cultured in surface modified gelatin/fibrinogen/PCL electrospun scaffolds. hCB-ECs growing in the scaffolds showed similar or superior behavior to human umbilical vein ECs (HUVEC) in terms of platelet deposition and activation, producing eNOS, and responding to a proinflammatory stimulus. Our data suggests that a biofunctional biopolymer based TEVG can be fabricated that can control SMC response and promote the formation of a functional endothelium


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Ardila, Diana Catalinadca13@pitt.edudca13
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairVande Geest, Jonathanjpv20@pitt.edujpv20
Committee MemberWagner, Williamwagnerwr@upmc.eduwagnerwr
Committee MemberBrown, Bryanbrownb@upmc.edubrownb
Committee MemberDoetschman,
Date: 23 January 2019
Date Type: Publication
Defense Date: 26 September 2018
Approval Date: 23 January 2019
Submission Date: 1 October 2018
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Number of Pages: 164
Institution: University of Pittsburgh
Schools and Programs: Swanson School of Engineering > Bioengineering
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: tissue engineered vascular graft, electrospinning, TGFb2, smooth muscle cells, human cord blood derived endothelial cells
Date Deposited: 23 Jan 2019 16:52
Last Modified: 23 Jan 2024 06:15


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item